I‐Hsun Li

655 total citations
48 papers, 494 citations indexed

About

I‐Hsun Li is a scholar working on Cellular and Molecular Neuroscience, Sensory Systems and Neurology. According to data from OpenAlex, I‐Hsun Li has authored 48 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 8 papers in Sensory Systems and 8 papers in Neurology. Recurrent topics in I‐Hsun Li's work include Psoriasis: Treatment and Pathogenesis (7 papers), Neuroscience and Neuropharmacology Research (7 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). I‐Hsun Li is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (7 papers), Neuroscience and Neuropharmacology Research (7 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). I‐Hsun Li collaborates with scholars based in Taiwan, United Kingdom and United States. I‐Hsun Li's co-authors include Kuo‐Hsing Ma, Yuahn‐Sieh Huang, Li‐Ting Kao, Cheng‐Yi Cheng, Chyng‐Yann Shiue, Ren-Shyan Liu, Mei-Hsiu Liao, Chang‐Min Liang, Ming‐Kung Yeh and Wen-Sheng Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and NeuroImage.

In The Last Decade

I‐Hsun Li

44 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I‐Hsun Li Taiwan 15 151 100 76 49 49 48 494
Tony K.Y. Lim Canada 12 158 1.0× 121 1.2× 55 0.7× 47 1.0× 28 0.6× 16 633
Mei-Hsiu Liao Taiwan 12 115 0.8× 107 1.1× 64 0.8× 128 2.6× 7 0.1× 21 444
Joseph A. Schroeder United States 16 340 2.3× 316 3.2× 72 0.9× 30 0.6× 13 0.3× 29 683
Gilson Gonçalves dos Santos United States 14 119 0.8× 138 1.4× 49 0.6× 89 1.8× 24 0.5× 24 531
Li-Yen Huang United States 13 319 2.1× 343 3.4× 48 0.6× 53 1.1× 38 0.8× 27 766
Ofer Jacobowitz United States 17 189 1.3× 451 4.5× 42 0.6× 21 0.4× 24 0.5× 37 1.1k
Fatma Töre Türkiye 16 181 1.2× 120 1.2× 25 0.3× 24 0.5× 53 1.1× 32 658
Judit Gál Hungary 9 198 1.3× 170 1.7× 87 1.1× 36 0.7× 17 0.3× 13 536
Jessica Chen United States 8 118 0.8× 119 1.2× 39 0.5× 24 0.5× 180 3.7× 13 480
Jung-Chul Seo South Korea 14 66 0.4× 117 1.2× 75 1.0× 127 2.6× 13 0.3× 51 592

Countries citing papers authored by I‐Hsun Li

Since Specialization
Citations

This map shows the geographic impact of I‐Hsun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Hsun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Hsun Li more than expected).

Fields of papers citing papers by I‐Hsun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I‐Hsun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Hsun Li. The network helps show where I‐Hsun Li may publish in the future.

Co-authorship network of co-authors of I‐Hsun Li

This figure shows the co-authorship network connecting the top 25 collaborators of I‐Hsun Li. A scholar is included among the top collaborators of I‐Hsun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I‐Hsun Li. I‐Hsun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Shih‐Yu, et al.. (2025). The investigation of effects, signal pathways, and applications of high glucose on dental pulp stem cells. Journal of Dental Sciences. 20(3). 1731–1738.
2.
Liu, Cheng‐Tsung, et al.. (2025). C18:0 GM3 ganglioside’s efficacy in LPS-induced parkinsonism: neuroprotection, inflammatory inhibition and gliosis mitigation. Behavioral and Brain Functions. 21(1). 25–25.
3.
Li, I‐Hsun, et al.. (2021). Association of Benzodiazepine Receptor Agonist Use With Changes in Psoriasis Severity in Adult Population: A Population-Based Study. Frontiers in Pharmacology. 12. 596375–596375. 1 indexed citations
4.
Lin, Po Ting, et al.. (2021). Illegal Drug Use and Risk of Hearing Loss in the United States: A National Health and Nutrition Examination Survey. International Journal of Environmental Research and Public Health. 18(22). 11945–11945. 3 indexed citations
6.
Li, I‐Hsun, et al.. (2020). Protective Effects of Anti-depressants against the Subsequent Development of Psoriasis in Patients with Major Depressive Disorder: a Cohort Study. Journal of Affective Disorders. 281. 590–596. 14 indexed citations
7.
Kao, Li‐Ting, et al.. (2020). Illicit drugs, cannabis, and psoriasis in the United States: National Health and Nutrition Examination Survey. Journal of the American Academy of Dermatology. 82(6). 1514–1517. 4 indexed citations
8.
Lin, Yi‐Chang, Chien‐Sung Tsai, I‐Hsun Li, et al.. (2019). Transplant Recipients Using Tacrolimus Had Higher Utilization of Healthcare Services Than Those Receiving Cyclosporine in Taiwan. Frontiers in Pharmacology. 10. 1074–1074. 1 indexed citations
9.
Liu, Cheng‐Tsung, Li‐Ting Kao, Wu‐Chien Chien, et al.. (2019). The effect of dextromethorphan use in Parkinson's disease: A 6-hydroxydopamine rat model and population-based study. European Journal of Pharmacology. 862. 172639–172639. 12 indexed citations
11.
Liu, Cheng‐Tsung, Yuahn‐Sieh Huang, Hsin‐Chien Chen, et al.. (2019). Evaluation of brain SERT with 4-[18F]-ADAM/micro-PET and hearing protective effects of dextromethorphan in hearing loss rat model. Toxicology and Applied Pharmacology. 378. 114604–114604. 2 indexed citations
12.
Kao, Li‐Ting, et al.. (2018). Pioglitazone use and Parkinson’s disease: a retrospective cohort study in Taiwan. BMJ Open. 8(8). e023302–e023302. 25 indexed citations
13.
Ma, Kuo‐Hsing, Cheng‐Yi Cheng, Li‐Heng Pao, et al.. (2015). Evaluation of brain SERT occupancy by resveratrol against MDMA-induced neurobiological and behavioral changes in rats: A 4-[ 18 F]-ADAM/small-animal PET study. European Neuropsychopharmacology. 26(1). 92–104. 15 indexed citations
14.
Li, I‐Hsun, et al.. (2015). Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine (‘ecstasy’)-induced serotonergic neurotoxicity. NeuroToxicology. 52. 114–126. 11 indexed citations
15.
Yeh, Ming‐Kung, et al.. (2014). Development of Yersinia pestis F1 antigen-loaded microspheres vaccine against plague. International Journal of Nanomedicine. 9. 813–813. 22 indexed citations
16.
Tsai, Tung‐Han, I‐Hsun Li, P.C. Lu, et al.. (2014). Neurotrophic and neuroprotective potential of human limbus-derived mesenchymal stromal cells. Cytotherapy. 16(10). 1371–1383. 17 indexed citations
17.
Wang, Chih‐Hung, Hsin‐Chien Chen, I‐Hsun Li, et al.. (2012). Investigating the effects of noise-induced hearing loss on serotonin transporters in rat brain using 4-[18F]-ADAM/small animal PET. NeuroImage. 75. 262–269. 20 indexed citations
18.
Wang, Mengting, et al.. (2011). Exposure to Sennoside–Digoxin Interaction and Risk of Digoxin Toxicity: A Population-Based Nested Case–Control Study. European Journal of Heart Failure. 13(11). 1238–1243. 8 indexed citations
19.
Chen, Yuan, Wen-Sheng Huang, Yaoh‐Shiang Lin, et al.. (2011). Characterization of 4-[18F]-ADAM as an imaging agent for SERT in non-human primate brain using PET: a dynamic study. Nuclear Medicine and Biology. 39(2). 279–285. 28 indexed citations
20.
Li, I‐Hsun, Chyng‐Yann Shiue, Ya-Yao Huang, et al.. (2009). Study on the neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PET. NeuroImage. 49(2). 1259–1270. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026